3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Glioblastoma
8
Colorectal Neoplasms
7
Carcinoma, Hepatocellular
7
Carcinoma, Non-Small-Cell Lung
5
Brain Neoplasms
5
Rectal Neoplasms
4
Glioma
4
Breast Neoplasms
4
Neoplasms
3
Meningeal Carcinomatosis
3
Lung Neoplasms
3
Colonic Neoplasms
3
Ovarian Neoplasms
2
Melanoma
2
Hypertension
2
Carcinoma, Renal Cell
2
Breast Neoplasms, Male
2
Uveal Melanoma
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Neoplasms, Nerve Tissue
1
Neoplasm Metastasis
1
Multi-organ Metastatic Colorectal Cancer
1
Liver Neoplasms
1
Fallopian Tube Neoplasms
1
Central Nervous System Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Non-squamous Non-Small Cell Lung Cancer
1
Interventions
spartalizumab
1
pembrolizumab
1
Platinum
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Non-small Cell Lung Cancer Metastatic
×
Bevacizumab
×
Clear all
NCT05407155
2026-04-23
BETTER
Fudan University
Phase NA
Active not recruiting
56 enrolled